Abstract
Dravet syndrome (DS) is a childhood epilepsy syndrome caused by heterozygous mutations in the SCN1A gene encoding voltage-gated sodium channel Nav1.1. We generated iPSCs from fibroblasts of three DS patients carrying distinct SCN1A mutations (c.5502-5509dupGCTTGAAC, c.2965G>C and c.651C>G). The iPSC lines were genetically stable and each line retained the SCN1A gene mutation of the donor fibroblasts. Characterization of the iPSC lines confirmed expression of pluripotency markers, absence of exogenous vector expression and trilineage differentiation potential. These iPSC lines offer a useful resource to investigate the molecular mechanisms underlying Nav1.1 haploinsufficiency and for drug development to improve treatment of DS patients.
Copyright © 2019 The Authors. Published by Elsevier B.V. All rights reserved.
Publication types
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Cell Differentiation / genetics
-
Cell Differentiation / physiology
-
Cellular Reprogramming / genetics
-
Cellular Reprogramming / physiology
-
Epilepsies, Myoclonic / genetics*
-
Humans
-
Induced Pluripotent Stem Cells / cytology*
-
Induced Pluripotent Stem Cells / metabolism
-
Kruppel-Like Factor 4
-
Kruppel-Like Transcription Factors / genetics
-
Kruppel-Like Transcription Factors / metabolism
-
Mutation / genetics
-
NAV1.1 Voltage-Gated Sodium Channel / genetics*
-
Octamer Transcription Factor-3 / genetics
-
Octamer Transcription Factor-3 / metabolism
-
SOXB1 Transcription Factors / genetics
-
SOXB1 Transcription Factors / metabolism
Substances
-
Kruppel-Like Factor 4
-
Kruppel-Like Transcription Factors
-
NAV1.1 Voltage-Gated Sodium Channel
-
Octamer Transcription Factor-3
-
SCN1A protein, human
-
SOX2 protein, human
-
SOXB1 Transcription Factors